Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning a 250-page SaaS filing to find DocuSign’s subscription growth or stock-based compensation details can derail your research day. DocuSign’s disclosures span revenue recognition rules, multi-year deferred revenue schedules, and evolving AI product lines—information that’s crucial yet hard to isolate.
Our platform fixes that. Stock Titan automatically ingests every DocuSign quarterly earnings report 10-Q filing and annual report 10-K simplified, then generates AI-powered summaries that spotlight customer count trends, remaining performance obligations, and key risk updates. Need to monitor DocuSign insider trading Form 4 transactions? Real-time alerts flag each DocuSign Form 4 insider transactions real-time, letting you track executive stock transactions Form 4 before the market reacts. When DocuSign posts an 8-K material events explained—like an acquisition or CEO change—we decode it so you don’t miss the strategic impact.
You’ll also find:
- Proxy statement sections on DocuSign proxy statement executive compensation, distilled into plain language.
- Interactive charts that turn DocuSign earnings report filing analysis into clear quarter-over-quarter visuals.
- Step-by-step guidance for understanding DocuSign SEC documents with AI, including footnote cross-links and glossary support.
DocuSign, Inc. (DOCU) filed a Form 144 disclosing that the Daniel Springer Revocable Trust, identified as a former affiliate, plans to sell up to 66,882 common shares on or about 26 June 2025. The shares will be sold through Morgan Stanley Smith Barney LLC on the Nasdaq exchange. At the 4 June 2025 market price implied by the filing, the transaction represents an aggregate market value of approximately US$5.04 million, equating to an implied price of roughly US$75.31 per share.
The proposed sale represents less than 0.04 % of DocuSign’s 202,062,772 shares outstanding, indicating limited dilution or market overhang risk. The securities were originally acquired via open-market purchase on 15 March 2022 and were fully paid for in cash. The filer reported no other sales in the past three months and affirmed that no undisclosed material adverse information is known.
Form 144 filings are routinely used by insiders and affiliates to notify the SEC of intended Rule 144 sales and do not obligate the seller to complete the transaction. Nevertheless, investors often monitor such filings as indicators of insider sentiment, even when the dollar amount is modest relative to the company’s market capitalization.
FAQ
What is the current stock price of Docusign (DOCU)?
What is the market cap of Docusign (DOCU)?
